Related references
Note: Only part of the references are listed.Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis
Avirup Guha et al.
EUROPEAN HEART JOURNAL (2022)
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
Joerg Herrmann et al.
EUROPEAN HEART JOURNAL (2022)
Pathophysiology of Takotsubo syndrome - a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology - Part 2: vascular pathophysiology, gender and sex hormones, genetics, chronic cardiovascular problems and clinical implications
Elmir Omerovic et al.
EUROPEAN JOURNAL OF HEART FAILURE (2022)
Pathophysiology of Takotsubo syndrome - a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology - Part 1: overview and the central role for catecholamines and sympathetic nervous system
Elmir Omerovic et al.
EUROPEAN JOURNAL OF HEART FAILURE (2022)
Immune-checkpoint inhibitors: long-term implications of toxicity
Douglas B. Johnson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Early parental knowledge of late effect risks in children with cancer
Kendall Carpenter et al.
PEDIATRIC BLOOD & CANCER (2022)
The role of exercise in the prevention of cancer therapy-related cardiac dysfunction in breast cancer patients undergoing chemotherapy: systematic review
James Murray et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)
Non-invasive imaging in coronary syndromes: recommendations of the European Association of Cardiovascular Imaging and the American Society of Echocardiography, in collaboration with the American Society of Nuclear Cardiology, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance
Thor Edvardsen et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2022)
A Combined Echocardiography Approach for the Diagnosis of Cancer Therapy-Related Cardiac Dysfunction in Women With Early-Stage Breast Cancer
Maryam Esmaeilzadeh et al.
JAMA CARDIOLOGY (2022)
Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxis
Katrina Piedra et al.
BRITISH JOURNAL OF HAEMATOLOGY (2022)
Circulating microRNAs predispose to takotsubo syndrome following high-dose adrenaline exposure
Liam S. Couch et al.
CARDIOVASCULAR RESEARCH (2022)
2021 ESC/EACTS Guidelines for the management of valvular heart disease Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
Alec Vahanian et al.
EUROPEAN HEART JOURNAL (2022)
Cardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association
Craig J. Beavers et al.
CIRCULATION (2022)
Prospective Cardiovascular Surveillance of Immune Checkpoint Inhibitor-Based Combination Therapy in Patients With Advanced Renal Cell Cancer: Data From the Phase III JAVELIN Renal 101 Trial
Brian Rini et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working Group on pulmonary circulation and right ventricular function
Lucia Mazzolai et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death Developed by the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) Endorsed by the Association for European Paediatric and Congenital Cardiology (AEPC)
Katja Zeppenfeld et al.
EUROPEAN HEART JOURNAL (2022)
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery Developed by the task force for cardiovascular assessment and management of patients undergoing non-cardiac surgery of the European Society of Cardiology (ESC) Endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC)
Sigrun Halvorsen et al.
EUROPEAN HEART JOURNAL (2022)
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG)
Marc Humbert et al.
EUROPEAN HEART JOURNAL (2022)
European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomes
Suleman Aktaa et al.
EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2022)
Cardiovascular risk factors during cancer treatment. Prevalence and prognostic relevance: insights from the CARDIOTOX registry
Juan Caro-Codon et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)
The benefits of exercise in cancer patients and the criteria for exercise prescription in cardio-oncology
Flavio D'Ascenzi et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)
Effects of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use on cancer therapy-related cardiac dysfunction: a meta-analysis of randomized controlled trials
Kuaifa Fang et al.
HEART FAILURE REVIEWS (2021)
A portable survivorship care plan: a tool that helps educate and improve knowledge in childhood cancer survivors
Patricia Murphy et al.
SUPPORTIVE CARE IN CANCER (2021)
Identification of anticancer drugs associated with atrial fibrillation: analysis of the WHO pharmacovigilance database
Joachim Alexandre et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2021)
Assessment of coronary artery disease during hospitalization for cancer treatment
Simone M. Mrotzek et al.
CLINICAL RESEARCH IN CARDIOLOGY (2021)
Clinical prevalence and outcome of cardiovascular events in the first 100 days postallogeneic hematopoietic stem cell transplant
Rehab Alblooshi et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2021)
Chronic thromboembolic pulmonary hypertension and totally implantable central venous access systems
Mitja Jevnikar et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Differential Impact of Gonadotropin-releasing Hormone Antagonist Versus Agonist on Clinical Safety and Oncologic Outcomes on Patients with Metastatic Prostate Cancer: A Meta-analysis of Randomized Controlled Trials
Mohammad Abufaraj et al.
EUROPEAN UROLOGY (2021)
Coronary and aortic calcification are associated with cardiovascular events on immune checkpoint inhibitor therapy
Walter B. Schiffer et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)
The role of induction therapy before autologous stem cell transplantation in low disease burden AL amyloidosis patients
Xianghua Huang et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2021)
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Jean-Philippe Collet et al.
EUROPEAN HEART JOURNAL (2021)
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Gerhard Hindricks et al.
EUROPEAN HEART JOURNAL (2021)
High-Intensity Interval Training in Older Adults: a Scoping Review
Catherine F. S. Marriott et al.
SPORTS MEDICINE-OPEN (2021)
Transcatheter Compared With Surgical Aortic Valve Replacement in Patients With Previous Chest-Directed Radiation Therapy
Farhang Yazdchi et al.
JACC: CARDIOONCOLOGY (2021)
Cardiovascular Manifestations From Therapeutic Radiation A Multidisciplinary Expert Consensus Statement From the International Cardio-Oncology Society
Joshua D. Mitchell et al.
JACC: CARDIOONCOLOGY (2021)
Early Cardiac Toxicity Associated With Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation
Remy Dulery et al.
JACC: CARDIOONCOLOGY (2021)
Past, Present, and Future of Radiation-Induced Cardiotoxicity: Refinements in Targeting, Surveillance, and Risk Stratification
Carmen Bergom et al.
JACC: CARDIOONCOLOGY (2021)
Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active Cancer
Steven Deitelzweig et al.
JACC: CARDIOONCOLOGY (2021)
Risk of Atrial Fibrillation According to Cancer Type A Nationwide Population-Based Study
Jun Pil Yun et al.
JACC: CARDIOONCOLOGY (2021)
Coronary Artery Disease in Young Women After Radiation Therapy for Breast Cancer The WECARE Study
Lauren E. Carlson et al.
JACC: CARDIOONCOLOGY (2021)
Cardiorespiratory fitness and survival following cancer diagnosis
Alexander Fardman et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)
Prevention of anthracycline-induced cardiotoxicity: a systematic review and meta-analysis
Francesca Caspani et al.
INTERNAL AND EMERGENCY MEDICINE (2021)
Cardiovascular Toxicity and Mortality Associated With Adoptive Cell Therapy and Tumor-infiltrating Lymphocytes for Advanced Stage Melanoma
Michael G. Fradley et al.
JOURNAL OF IMMUNOTHERAPY (2021)
Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis
Marco Valerio Mariani et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)
The 4S-AF Scheme (Stroke Risk; Symptoms; Severity of Burden; Substrate): A Novel Approach to In-Depth Characterization (Rather than Classification) of Atrial Fibrillation
Tatjana S. Potpara et al.
THROMBOSIS AND HAEMOSTASIS (2021)
Left ventricular thrombus on cardiovascular magnetic resonance imaging in non-ischaemic cardiomyopathy
Matthew Hooks et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2021)
Meta-analysis Evaluating the Use of Statins to attenuate Cardiotoxicity in Cancer Patients receiving Anthracyclines and Trastuzumab-based Chemotherapy
Izza Shahid et al.
AMERICAN JOURNAL OF CARDIOLOGY (2021)
Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies in patients with breast cancer and compromised heart function
Katia Khoury et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Multidisciplinary consensus on cancer management during pregnancy
A. Cubillo et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2021)
The risk of cardiac events in patients receiving immune checkpoint inhibitors a nationwide Danish study
Maria D'Souza et al.
EUROPEAN HEART JOURNAL (2021)
Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis
John R. Power et al.
CIRCULATION (2021)
Cardiac Safety of Osimertinib: A Review of Data
Michael S. Ewer et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients
Simone de Vries et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Cardiovascular disease and its management in children and adults undergoing hematopoietic stem cell transplantation
Seth J. Rotz et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)
Coronary artery disease surveillance among childhood, adolescent and young adult cancer survivors: A systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group
Elvira C. van Dalen et al.
EUROPEAN JOURNAL OF CANCER (2021)
Stratification and management of cardiovascular risk in cancer patients. A consensus document of the SEC, FEC, SEOM, SEOR, SEHH, SEMG, AEEMT, AEEC, and AECC
Ana Martin Garcia et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2021)
Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study
Walter Ageno et al.
THROMBOSIS AND HAEMOSTASIS (2021)
Comparison of Different Clinical Prognostic Scores in Patients with Pulmonary Embolism and Active Cancer
Xiaoqian Li et al.
THROMBOSIS AND HAEMOSTASIS (2021)
Fast Strain-Encoded Cardiac Magnetic Resonance for Diagnostic Classification and Risk Stratification of Heart Failure Patients
Grigorios Korosoglou et al.
JACC-CARDIOVASCULAR IMAGING (2021)
Anticoagulation for atrial fibrillation in active cancer: what the cardiologists think
Dimitrios Farmakis
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)
Statin Exposure and Risk of Heart Failure After Anthracycline- or Trastuzumab-Based Chemotherapy for Early Breast Cancer: A Propensity Score-Matched Cohort Study
Husam Abdel-Qadir et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Procedural and Short-Term Outcomes of Percutaneous Left Atrial Appendage Closure in Patients With Cancer
Toshiaki Isogai et al.
AMERICAN JOURNAL OF CARDIOLOGY (2021)
Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy
Adam Goldman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: A nationwide cohort study
Daniele Pastori et al.
CANCER (2021)
ALK inhibitor-induced bradycardia: A systematic-review and meta-analysis
Filipe Cirne et al.
LUNG CANCER (2021)
Percutaneous coronary intervention in patients with cancer and readmissions within 90 days for acutemyocardial infarction and bleeding in the USA
Chun Shing Kwok et al.
EUROPEAN HEART JOURNAL (2021)
Mean Heart Dose Is an Inadequate Surrogate for Left Anterior Descending Coronary Artery Dose and the Risk of Major Adverse Cardiac Events in Lung Cancer Radiation Therapy
Katelyn M. Atkins et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
2020 ACC/AHA Guideline on the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines (vol 77, pg e25, 2021)
Otto
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy
Paaladinesh Thavendiranathan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Cardiac Toxicity of Thoracic Radiotherapy: Existing Evidence and Future Directions
Kathryn Banfill et al.
JOURNAL OF THORACIC ONCOLOGY (2021)
Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer
Dristhi Ragoonanan et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
EACVI recommendations on cardiovascular imaging for the detection of embolic sources: endorsed by the Canadian Society of Echocardiography
Ariel Cohen et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2021)
Impact of Medical Castration on Malignant Arrhythmias in Patients With Prostate Cancer
Kanae Hasegawa et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Association of Breast Cancer Irradiation With Cardiac Toxic Effects A Narrative Review
Icro Meattini et al.
JAMA ONCOLOGY (2021)
Effect of primary percutaneous coronary intervention on in-hospital outcomes among active cancer patients presenting with ST-elevation myocardial infarction: a propensity score matching analysis
Mohamed O. Mohamed et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2021)
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer
Gary H. Lyman et al.
BLOOD ADVANCES (2021)
Early Detection of Checkpoint Inhibitor-Associated Myocarditis Using 68Ga-FAPI PET/CT
Daniel Finke et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer
Nicolo Matteo Luca Battisti et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Immune checkpoint inhibitors-associated pericardial disease: a systematic review of case reports
Alessandro Inno et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Cardiotoxicity of Epidermal Growth Factor Receptor 2-Targeted Drugs for Breast Cancer
ZiYan Yang et al.
FRONTIERS IN PHARMACOLOGY (2021)
Cardiovascular Issues in Hematopoietic Stem Cell Transplantation (HSCT)
Teresa Lopez-Fernandez et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2021)
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
Jan Steffel et al.
EUROPACE (2021)
Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
Pablo Garcia-Pavia et al.
EUROPEAN JOURNAL OF HEART FAILURE (2021)
Role of cardiovascular magnetic resonance in early detection and treatment of cardiac dysfunction in oncology patients
Srilakshmi Vallabhaneni et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2021)
68Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis
Sarah Boughdad et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
State-of-Art of Cellular Therapy for Acute Leukemia
Jong-Bok Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis
Paaladinesh Thavendiranathan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
The Role of Healthy Lifestyle in Cancer Incidence and Temporal Transitions to Cardiometabolic Disease
Zhi Cao et al.
JACC: CARDIOONCOLOGY (2021)
Healthy Lifestyle Benefits Both Cancer and Cardiovascular Disease
Erin D. Michos et al.
JACC: CARDIOONCOLOGY (2021)
Serial Cardiovascular Magnetic Resonance Strain Measurements to Identify Cardiotoxicity in Breast Cancer Comparison With Echocardiography
Christian P. Houbois et al.
JACC-CARDIOVASCULAR IMAGING (2021)
Angiotensin System Inhibitors May Improve Outcomes of Patients With Castration-Resistant Prostate Cancer During Abiraterone Acetate Treatment-A Cardio-Oncology Study
Michal Wilk et al.
FRONTIERS IN ONCOLOGY (2021)
Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System: Effects and Modifications: A Scientific Statement From the American Heart Association
Tochi M. Okwuosa et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2021)
Cardiac complications associated with hematopoietic stem-cell transplantation
Akihiro Ohmoto et al.
BONE MARROW TRANSPLANTATION (2021)
Statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta-analysis
Mary Obasi et al.
CANCER CAUSES & CONTROL (2021)
Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association
Michael G. Fradley et al.
CIRCULATION (2021)
Multiparametric Early Detection and Prediction of Cardiotoxicity Using Myocardial Strain, T1 and T2 Mapping, and Biochemical Markers A Longitudinal Cardiac Resonance Imaging Study During 2 Years of Follow-Up
Sorin Giusca et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2021)
Characteristics and Outcomes of Women Developing Heart Failure After Early Stage Breast Cancer Chemotherapy: A Population-Based Matched Cohort Study
Husam Abdel-Qadir et al.
CIRCULATION-HEART FAILURE (2021)
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
Frank L. J. Visseren et al.
EUROPEAN HEART JOURNAL (2021)
Anticancer drug-induced life-threatening ventricular arrhythmias: a World health Organization pharmacovigilance study
Joe-Elie Salem et al.
EUROPEAN HEART JOURNAL (2021)
Satin associated lower cancer risk and related mortaity in patients with heart failure
Qing-Wen Ren et al.
EUROPEAN HEART JOURNAL (2021)
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA)
Michael Glikson et al.
EUROPEAN HEART JOURNAL (2021)
Cardiovascular immunotoxicities associated with immune checkpoint inhibitors: a safety meta-analysis
Charles Dolladille et al.
EUROPEAN HEART JOURNAL (2021)
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Theresa A. McDonagh et al.
EUROPEAN HEART JOURNAL (2021)
Cardiotoxicity associated with immune checkpoint inhibitor therapy: a meta-analysis
Nestor Rubio-Infante et al.
EUROPEAN JOURNAL OF HEART FAILURE (2021)
Immune checkpoint inhibitor myocarditis: elucidating the spectrum of disease through endomyocardial biopsy
Nicolas L. Palaskas et al.
EUROPEAN JOURNAL OF HEART FAILURE (2021)
Cardiovascular Risk Associated With Ibrutinib Use in Chronic Lymphocytic Leukemia: A Population-Based Cohort Study
Husam Abdel-Qadir et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial
John C. Byrd et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Clinical Approach to Cardiovascular Toxicity of Oral Antineoplastic Agents JACC State-of-the-Art Review
Vijay U. Rao et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis
E. Kastritis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Safety of FLT3 inhibitors in patients with acute myeloid leukemia
Claudio Cerchione et al.
EXPERT REVIEW OF HEMATOLOGY (2021)
Radiation-Induced Cardiovascular Disease: Review of an Underrecognized Pathology
Eve Belzile-Dugas et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Mortality associated with the use of non-vitamin K antagonist oral anticoagulants in cancer patients: Dabigatran versus rivaroxaban
Yu-Sheng Lin et al.
CANCER MEDICINE (2021)
Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis A Narrative Review
Lorenz H. Lehmann et al.
JAMA CARDIOLOGY (2021)
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
Julie R. Brahmer et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Pericardial disease in patients treated with immune checkpoint inhibitors
Jingyi Gong et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Statin Use Can Attenuate the Decline in Left Ventricular Ejection Fraction and the Incidence of Cardiomyopathy in Cardiotoxic Chemotherapy Recipients: A Systematic Review and Meta-Analysis
Jean Kim et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and the ESC council of Cardio-Oncology-Part 1: acute coronary syndromes and acute pericardial diseases
Sofie A. Gevaert et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2021)
Clinical implications of isolated troponinemia following immune checkpoint inhibitor therapy
D. Delombaerde et al.
ESMO OPEN (2021)
Myocarditis related to immune checkpoint inhibitors treatment: two case reports and literature review
Yukai Chen et al.
ANNALS OF PALLIATIVE MEDICINE (2021)
Anticoagulation in patients with atrial fibrillation and active cancer: an international survey on patient management
Giuseppe Boriani et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)
The Evolving Immunotherapy Landscape and the Epidemiology, Diagnosis, and Management of Cardiotoxicity JACC: CardioOncology Primer
Lili Zhang et al.
JACC: CARDIOONCOLOGY (2021)
Refining the 10-Year Prediction of Left Ventricular Systolic Dysfunction in Long-Term Survivors of Childhood Cancer
Jan M. Leerink et al.
JACC: CARDIOONCOLOGY (2021)
Effectiveness and Safety of Apixaban, Low-Molecular-Weight Heparin, and Warfarin among Venous Thromboembolism Patients with Active Cancer: A US Claims Data Analysis
Alexander Cohen et al.
THROMBOSIS AND HAEMOSTASIS (2021)
Cardiovascular risk assessment and management of patients undergoing hematopoietic cell transplantation
Guilherme H. Oliveira et al.
BONE MARROW TRANSPLANTATION (2021)
Cardiac biomarkers and association with subsequent cardiomyopathy and mortality among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort
Stephanie B. Dixon et al.
CANCER (2021)
The risk of cardiac events in patients receiving immune checkpoint inhibitors: a nationwide Danish study
Maria D'Souza et al.
EUROPEAN HEART JOURNAL (2021)
Statin associated lower cancer risk and related mortality in patients with heart failure
Qing-Wen Ren et al.
EUROPEAN HEART JOURNAL (2021)
Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis
Andrea Baggiano et al.
JACC-CARDIOVASCULAR IMAGING (2020)
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Francesco Cosentino et al.
EUROPEAN HEART JOURNAL (2020)
2019 ESC Guidelines for the dignosis and management of acute pulmonary embolism development Toed in colaboration with the European Respiratory Society (ERS)
Stavros Konstantinides et al.
EUROPEAN HEART JOURNAL (2020)
2019 ESC Guidelines for the management of patients with supraventricular tachycardia The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC): Developed in collaboration with the Association for European Paediatric and Congenital Cardiology (AEPC)
Josep Brugada et al.
EUROPEAN HEART JOURNAL (2020)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)
Juhani Knuuti et al.
EUROPEAN HEART JOURNAL (2020)
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
Nigel S. Key et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Comprehensive Assessment of Changes in Left Ventricular Diastolic Function With Contemporary Breast Cancer Therapy
Jenica N. Upshaw et al.
JACC-CARDIOVASCULAR IMAGING (2020)
A pooled analysis of the cardiac events in the trastuzumab adjuvant trials
Evandro de Azambuja et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Measuring cardiopulmonary complications of carfilzomib treatment and associated risk factors using the SEER-Medicare database
Bita Fakhri et al.
CANCER (2020)
Myocardial dysfunction in long-term breast cancer survivors treated at ages 40-50years
Judy N. Jacobse et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Troponins and brain natriuretic peptides for the prediction of cardiotoxicity in cancer patients: a meta-analysis
Lars Michel et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial
Robert D. McBane et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Association between statin use and all-cause mortality in cancer survivors, based on the Korean health insurance service between 2002 and 2015
Joungyoun Kim et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2020)
The Meaningless Meaning of Mean Heart Dose in Mediastinal Lymphoma in the Modern Radiation Therapy Era
Bradford S. Hoppe et al.
PRACTICAL RADIATION ONCOLOGY (2020)
Contemporary Trends and Outcomes of Percutaneous and Surgical Mitral Valve Replacement or Repair in Patients With Cancer
Avirup Guha et al.
AMERICAN JOURNAL OF CARDIOLOGY (2020)
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
G. Curigliano et al.
ANNALS OF ONCOLOGY (2020)
Systematic review and meta-analysis of the prognostic impact of cancer among patients with acute coronary syndrome and/or percutaneous coronary intervention
Vincent Roule et al.
BMC CARDIOVASCULAR DISORDERS (2020)
Cardiology care delivered to cancer patients
Riccardo Asteggiano et al.
EUROPEAN HEART JOURNAL (2020)
Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry
Jose Lopez-Sendon et al.
EUROPEAN HEART JOURNAL (2020)
Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA
Aditya Bharadwaj et al.
EUROPEAN HEART JOURNAL (2020)
Long-term survivors of early breast cancer treated with chemotherapy are characterized by a pro-inflammatory biomarker profile compared to matched controls
Jasper Tromp et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Pericardial diseases in patients with cancer: contemporary prevalence, management and outcomes
Massimo Imazio et al.
HEART (2020)
Variability in echocardiography and MRI for detection of cancer therapy cardiotoxicity
James Lambert et al.
HEART (2020)
National prevalence, trends and outcomes of takotsubo syndrome in hospitalizations with prior history of mediastinal/intrathoracic cancer and radiation therapy
Rupak Desai et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)
Management of Acute and Recurrent Pericarditis JACC State-of-the-Art Review
Juan Guido Chiabrando et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis
Magid Awadalla et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer
Dennis J. Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer
Shanu Modi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Role of cardioprotective agents on chemotherapy-induced heart failure: A systematic review and network meta-analysis of randomized controlled trials
Xinye Li et al.
PHARMACOLOGICAL RESEARCH (2020)
Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors
Charles Dolladille et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Radiotherapy in Patients With a Cardiac Implantable Electronic Device
Ardalan Sharifzadehgan et al.
AMERICAN JOURNAL OF CARDIOLOGY (2020)
Multiple myeloma: 2020 update on diagnosis, risk-stratification and management
S. Vincent Rajkumar
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA
Giovanni Palladini et al.
BLOOD (2020)
Cumulative incidence of chemotherapy-induced cardiotoxicity during a 2-year follow-up period in breast cancer patients
Hyunsoon Cho et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial
Daniel Eiger et al.
BRITISH JOURNAL OF CANCER (2020)
Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agents
Robert F. Cornell et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association
Laxmi S. Mehta et al.
CIRCULATION (2020)
Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction
Biniyam G. Demissei et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
High-intensity interval training improves cardiorespiratory fitness in cancer patients and survivors: A meta-analysis
Matthew P. Wallen et al.
EUROPEAN JOURNAL OF CANCER CARE (2020)
Cardiotoxicity and myocardial hypoperfusion associated with anti-vascular endothelial growth factor therapies: prospective cardiac magnetic resonance imaging in patients with cancer
Stephen J. H. Dobbin et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from theCardio-OncologyStudyGroup of theHeartFailureAssociation of theEuropeanSociety ofCardiology in collaboration with theInternationalCardio-OncologySociety
Alexander R. Lyon et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
l A Meta-Analysis of Case Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding in Patients with Cancer
Alym Abdulla et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis
Michela Giustozzi et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Fatal heart disease among cancer patients
Kelsey C. Stoltzfus et al.
NATURE COMMUNICATIONS (2020)
Cardiac Events Associated With Chimeric Antigen Receptor T-Cells (CAR-T) A VigiBase Perspective
Joe-Elie Salem et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Diet, Lifestyle and Cardiovascular Diseases: Linking Pathophysiology to Cardioprotective Effects of Natural Bioactive Compounds
Javad Sharifi-Rad et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
Impact of statin use on cancer-specific mortality and recurrence A meta-analysis of 60 observational studies
Jing Yang et al.
MEDICINE (2020)
Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer
Charles Dolladille et al.
JAMA ONCOLOGY (2020)
Circulating MicroRNAs as Potential Predictors of Anthracycline-Induced Troponin Elevation in Breast Cancer Patients: Diverging Effects of Doxorubicin and Epirubicin
Sonia Gioffre et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Venous Thromboembolism in Cancer Patients on Simultaneous and Palliative Care
Silvia Riondino et al.
CANCERS (2020)
Cardiovascular Toxicity of Tyrosine Kinase Inhibitors Used in Chronic Myeloid Leukemia: An Analysis of the FDA Adverse Event Reporting System Database (FAERS)
Santa Cirmi et al.
CANCERS (2020)
Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
Joerg Herrmann
NATURE REVIEWS CARDIOLOGY (2020)
Vascular toxic effects of cancer therapies
Joerg Herrmann
NATURE REVIEWS CARDIOLOGY (2020)
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer
Neal D. Shore et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trial
Jennifer M. T. A. Meessen et al.
ESC HEART FAILURE (2020)
Cardiovascular Toxicity in Cancer Patients Treated with Tyrosine Kinase Inhibitors: A Real-World Single-Center Experience
Giuseppina Novo et al.
ONCOLOGY (2020)
Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated Myocarditis
Lili Zhang et al.
CIRCULATION (2020)
Statins Reduce Mortality in Multiple Myeloma: A Population-Based US Study
Amber Afzal et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)
Focused echocardiography in cardio-oncology
Kalliopi Keramida et al.
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES (2020)
Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities
Yves Allenbach et al.
AUTOIMMUNITY REVIEWS (2020)
Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)
Jelena Celutkiene et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Anticancer Therapy-Related Increases in Arterial Stiffness: A Systematic Review and Meta-Analysis
Shannon K. Parr et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Bortezomib, Melphalan, and Dexamethasone for Light-Chain Amyloidosis
Efstathios Kastritis et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Risk scores for occult cancer in patients with unprovoked venous thromboembolism: Results from an individual patient data meta-analysis
Frits Mulder et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Cardiovascular Events Associated with Chimeric Antigen Receptor T Cell Therapy: Cross-Sectional FDA Adverse Events Reporting System Analysis
Avirup Guha et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
HEMATOLOGIC COMPLICATIONS IN PREGNANCY How I treat lymphoma in pregnancy
Kieron Dunleavy et al.
BLOOD (2020)
Vascular aging in long-term survivors of testicular cancer more than 20 years after treatment with cisplatin-based chemotherapy
Johannes Stelwagen et al.
BRITISH JOURNAL OF CANCER (2020)
Outdoor air pollution and cancer: An overview of the current evidence and public health recommendations
Michelle C. Turner et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque
Zsofia D. Drobni et al.
CIRCULATION (2020)
Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association
James E. Tisdale et al.
CIRCULATION (2020)
The cancer patient and cardiology
Jose Luis Zamorano et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from theCardio-Oncology Study Groupof theHeart Failure Associationand theCardio-Oncology Council of the European Society of Cardiology
Radek Pudil et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Diagnostic Accuracy of Cardiac Computed Tomography and 18-F Fluorodeoxyglucose Positron Emission Tomography in Cardiac Masses
Emanuela Concetta D'Angelo et al.
JACC-CARDIOVASCULAR IMAGING (2020)
The Role of Biomarkers in Cardio-Oncology
Kajaluxy Ananthan et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2020)
Cardiac Biomarkers in Patients with Cancer: Considerations, Clinical Implications, and Future Avenues
Valentina Bracun et al.
CURRENT ONCOLOGY REPORTS (2020)
Multimodality imaging in cardiac amyloidosis: a primer for cardiologists
Ruxandra Jurcut et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2020)
Sex-Specific Associations of Cardiovascular Risk Factors and Biomarkers With Incident Heart Failure
Navin Suthahar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Effect of Anti-Inflammatory Drugs on Clinical Outcomes in Patients With Malignant Pericardial Effusion
So Ree Kim et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Cardioversion of recent-onset atrial fibrillation: current evidence, practical considerations, and controversies in a complex clinical scenario
Giuseppe Boriani et al.
KARDIOLOGIA POLSKA (2020)
By Releasing the Brakes With Immunotherapy, Are We Accelerating Atherosclerosis?
Lavanya Kondapalli et al.
CIRCULATION (2020)
First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events
Marcela Maus et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis
Jennifer Cautela et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Impact of Cancer in Patients Undergoing Transcatheter Aortic Valve Replacement A Single-Center Study
Alexander Lind et al.
JACC: CARDIOONCOLOGY (2020)
Strain Imaging in Cardio-Oncology
Jennifer E. Liu et al.
JACC: CARDIOONCOLOGY (2020)
Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Mediastinal Radiation
Ayman Elbadawi et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2020)
Can ACEI/ARB prevent the cardiotoxicity caused by chemotherapy in early-stage breast cancer?-a meta-analysis of randomized controlled trials
Haoran Dong et al.
TRANSLATIONAL CANCER RESEARCH (2020)
Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy An Expert Consensus Document
Enrico Ammirati et al.
CIRCULATION-HEART FAILURE (2020)
Genetics of Anthracycline Cardiomyopathy in Cancer Survivors JACC: CardioOncology State-of-the-Art Review
Smita Bhatia
JACC: CARDIOONCOLOGY (2020)
Chimeric Antigen Receptor T-Cell Therapy-Associated Cardiomyopathy in Patients With Refractory or Relapsed Non-Hodgkin Lymphoma
Sarju Ganatra et al.
CIRCULATION (2020)
Outcomes of percutaneous coronary interventions in cancer patients
Aditya S. Bharadwaj et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2020)
Concerns for Active Breathing Control (ABC) With Breast Cancer in the Era of COVID-19: Maximizing Infection Control While Minimizing Heart Dose
Andrew J. Song et al.
ADVANCES IN RADIATION ONCOLOGY (2020)
Ventricular Arrhythmias in Cardiac Amyloidosis: A Review of Current Literature
Shaun Khanna et al.
CLINICAL MEDICINE INSIGHTS-CARDIOLOGY (2020)
Cardiovascular Effects of CAR T Cell Therapy A Retrospective Study
Benedicte Lefebvre et al.
JACC: CARDIOONCOLOGY (2020)
Incremental Value of Global Longitudinal Strain for Predicting Survival in Patients With Advanced AL Amyloidosis
Katherine Lee Chuy et al.
JACC: CARDIOONCOLOGY (2020)
Cardiac Tumors JACC CardioOncology State-of-the-Art Review
Sara Tyebally et al.
JACC: CARDIOONCOLOGY (2020)
Impact of Cancer Therapy-Related Cardiac Dysfunction on Risk of Heart Failure in Pregnancy
Mark Nolan et al.
JACC: CARDIOONCOLOGY (2020)
Quantitative assessment of cardiovascular autonomic impairment in cancer survivors: a single center case series
Benjamin Noor et al.
CARDIO-ONCOLOGY (2020)
Outcomes after transcatheter aortic valve replacement in cancer survivors with prior chest radiation therapy: a systematic review and meta-analysis
Meer Rabeel Zafar et al.
CARDIO-ONCOLOGY (2020)
Incidence of Atrioventricular Block After Valve Replacement in Carcinoid Heart Disease
Igor Sunjic et al.
CARDIOLOGY RESEARCH (2020)
Association of post-diagnosis cardiorespiratory fitness with cause-specific mortality in cancer
John D. Groarke et al.
EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2020)
Plasma Hepatocyte Growth Factor for Diagnosis and Prognosis in Light Chain and Transthyretin Cardiac Amyloidosis
Kathleen W. Zhang et al.
JACC: CARDIOONCOLOGY (2020)
Cardiac Adverse Events in EGFR-Mutated Non-Small Cell Lung Cancer Treated With Osimertinib
Kei Kunimasa et al.
JACC: CARDIOONCOLOGY (2020)
Direct Oral Anticoagulants in Patients With Active Cancer A Systematic Review and Meta-Analysis
Jolanda Sabatino et al.
JACC: CARDIOONCOLOGY (2020)
Pregnancy in a healthy population: dynamics of NTproBNP and hs-cTroponin T
Eva Furenas et al.
OPEN HEART (2020)
Management of Arrhythmias in Cardiac Amyloidosis
Shaun Giancaterino et al.
JACC-CLINICAL ELECTROPHYSIOLOGY (2020)
European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS)
Giuseppe Boriani et al.
EUROPACE (2019)
Definition of hidden drug cardiotoxicity: paradigm change in cardiac safety testing and its clinical implications
Peter Ferdinandy et al.
EUROPEAN HEART JOURNAL (2019)
Cardio-Oncology Services: rationale, organization, and implementation A report from the ESC Cardio-Oncology council
Patrizio Lancellotti et al.
EUROPEAN HEART JOURNAL (2019)
Treatment of cancer-associated venous thromboembolism in the age of direct oral anticoagulants
C. Ay et al.
ANNALS OF ONCOLOGY (2019)
Cardiac outcomes of trastuzumab therapy in patients with HER2-positive breast cancer and reduced left ventricular ejection fraction
Yasin Hussain et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study
F. Lynce et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Stroke Prevention, Evaluation of Bleeding Risk, and Anticoagulant Treatment Management in Atrial Fibrillation Contemporary International Guidelines
Marco Proietti et al.
CANADIAN JOURNAL OF CARDIOLOGY (2019)
Cardiovascular toxicities associated with immune checkpoint inhibitors
Jiun-Ruey Hu et al.
CARDIOVASCULAR RESEARCH (2019)
Cardiac arrhythmia considerations of hormone cancer therapies
Mary Barber et al.
CARDIOVASCULAR RESEARCH (2019)
Cardio-Oncology: Vascular and Metabolic Perspectives A Scientific Statement From the American Heart Association
Umberto Campia et al.
CIRCULATION (2019)
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart
Giovanni Caocci et al.
HEMATOLOGICAL ONCOLOGY (2019)
Comparison of Framingham risk score and chest-CT identified coronary artery calcification in breast cancer patients to predict cardiovascular events
William J. Phillips et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
Therapy-Related Cardiac Risk in Childhood Cancer Survivors: An Analysis of the Childhood Cancer Survivor Study
James E. Bates et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Electronic Systems for Patients to Report and Manage Side Effects of Cancer Treatment: Systematic Review
Lorraine Warrington et al.
JOURNAL OF MEDICAL INTERNET RESEARCH (2019)
Direct Current Cardioversion of Atrial Arrhythmias in Adults With Cardiac Amyloidosis
Edward A. El-Am et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Anticoagulation Strategies in Patients With Cancer JACC Review Topic of the Week
Ramya C. Mosarla et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Risk factors for the development of atrial fibrillation on ibrutinib treatment
Robert Lentz et al.
LEUKEMIA & LYMPHOMA (2019)
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
A. A. Khorana et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Is mean heart dose a relevant surrogate parameter of left ventricle and coronary arteries exposure during breast cancer radiotherapy: a dosimetric evaluation based on individually-determined radiation dose (BACCARAT study)
Sophie Jacob et al.
RADIATION ONCOLOGY (2019)
High-intensity exercise during chemotherapy induces beneficial effects 12months into breast cancer survivorship
Sara Mijwel et al.
JOURNAL OF CANCER SURVIVORSHIP (2019)
Radiotherapy toxicity
Dirk De Ruysscher et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Derivation of Anthracycline and Anthraquinone Equivalence Ratios to Doxorubicin for Late-Onset Cardiotoxicity
Elizabeth A. M. Feijen et al.
JAMA ONCOLOGY (2019)
Effect of Aerobic and Resistance Exercise Intervention on Cardiovascular Disease Risk in Women With Early-Stage Breast Cancer A Randomized Clinical Trial
Kyuwan Lee et al.
JAMA ONCOLOGY (2019)
Examining the cost-effectiveness of baseline left ventricular function assessment among breast cancer patients undergoing anthracycline-based therapy
Maysa M. Abu-Khalaf et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Immune checkpoint inhibitor therapy and myocarditis: a systematic review of reported cases
Suheil Albert Atallah-Yunes et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
High Prevalence of Intracardiac Thrombi in Cardiac Amyloidosis
Ana Martinez-Naharro et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Prevention, Monitoring, and Management of Cardiac Dysfunction in Patients with Metastatic Breast Cancer
Giuseppe Curigliano et al.
ONCOLOGIST (2019)
Abordaje de la fibrilación auricular en pacientes con cáncer activo. Documento de consenso de expertos y recomendaciones
Teresa López-Fernández et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2019)
Cardiorespiratory fitness predicts cardiovascular health in breast cancer survivors, independent of body composition, age and time post-treatment completion
Lynnette M. Jones et al.
BREAST CANCER (2019)
Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement From the American Heart Association
Susan C. Gilchrist et al.
CIRCULATION (2019)
Genetic Variants Associated With Cancer Therapy-Induced Cardiomyopathy
Pablo Garcia-Pavia et al.
CIRCULATION (2019)
Myocarditis in the Setting of Cancer Therapeutics Proposed Case Definitions for Emerging Clinical Syndromes in Cardio-Oncology
Marc P. Bonaca et al.
CIRCULATION (2019)
Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention A Consensus Document From the Academic Research Consortium for High Bleeding Risk
Philip Urban et al.
CIRCULATION (2019)
Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP)
Xavier Rossello et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING (2019)
Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations
Christian Mueller et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Assessment of left ventricular function by CMR versus MUGA scans in breast cancer patients receiving trastuzumab: a prospective observational study
Vinita Dhir et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2019)
Randomized Trial of Lisinopril Versus Carvedilol to Prevent Trastuzumab Cardiotoxicity in Patients With Breast Cancer
Maya Guglin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Cardiopulmonary exercise testing in adult cardiology: expert opinion of the Working Group of Cardiac Rehabilitation and Exercise Physiology of the Polish Cardiac Society
Krzysztof Smarz et al.
KARDIOLOGIA POLSKA (2019)
Health Care Spending, Utilization, and Quality 8 Years into Global Payment
Zirui Song et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer
S. -A. Im et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Predictors of Mortality in Light Chain Cardiac Amyloidosis with Heart Failure
Usman A. Tahir et al.
SCIENTIFIC REPORTS (2019)
Radiation-Associated Pericardial Disease
Natalie Szpakowski et al.
CURRENT CARDIOLOGY REPORTS (2019)
A Retrospective Evaluation of Risk of Peripartum Cardiac Dysfunction in Survivors of Childhood, Adolescent and Young Adult Malignancies
Lori Chait-Rubinek et al.
CANCERS (2019)
Different Cardiotoxicity of Palbociclib and Ribociclib in Breast Cancer: Gene Expression and Pharmacological Data Analyses, Biological Basis, and Therapeutic Implications
Matteo Santoni et al.
BIODRUGS (2019)
Androgenic Effects on Ventricular Repolarization A Translational Study From the International Pharmacovigilance Database to iPSC-Cardiomyocytes
Joe-Elie Salem et al.
CIRCULATION (2019)
Development and validation of amultivariable prediction model for major adverse cardiovascular events after early stage breast cancer: a population-based cohort study
Husam Abdel-Qadir et al.
EUROPEAN HEART JOURNAL (2019)
Adverse events associated with encorafenib plus binimetinib in the COLUMBUS study: incidence, course and management
Helen J. Gogas et al.
EUROPEAN JOURNAL OF CANCER (2019)
Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma
Robert F. Cornell et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group
Michael Fuchs et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Management of radiotherapy patients with implanted cardiac pacemakers and defibrillators: A Report of the AAPM TG-203†
Moyed Miften et al.
MEDICAL PHYSICS (2019)
Evidence-based recommendations for the organization of long-term follow-up care for childhood and adolescent cancer survivors: a report from the PanCareSurFup Guidelines Working Group
Gisela Michel et al.
JOURNAL OF CANCER SURVIVORSHIP (2019)
Factors Associated With Immune Checkpoint Inhibitor-Related Myocarditis
Yoshito Zamami et al.
JAMA ONCOLOGY (2019)
Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-analysis
Evangelos K. Oikonomou et al.
JAMA CARDIOLOGY (2019)
Anti-PD-1 monoclonal antibody MEDI0680 in a phase I study of patients with advanced solid malignancies
Aung Naing et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis
Jack Brownrigg et al.
ESC HEART FAILURE (2019)
Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting
F. Amant et al.
ANNALS OF ONCOLOGY (2019)
Hypertension and incident cardiovascular events following ibrutinib initiation
Tyler Dickerson et al.
BLOOD (2019)
A population-based study of cardiovascular diseasemortality risk in US cancer patients
Kathleen M. Sturgeon et al.
EUROPEAN HEART JOURNAL (2019)
From trends to transformation: where cardio-oncology is to make a difference
Joerg Herrmann
EUROPEAN HEART JOURNAL (2019)
Cardiovascular Toxicities Associated With Ibrutinib
Joe-Elie Salem et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Cardiovascular Toxicities of Immune Checkpoint Inhibitors JACC Review Topic of the Week
Somedeb Ball et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
Dominique Farge et al.
LANCET ONCOLOGY (2019)
Effect of comprehensive initial training on the variability of left ventricular measures using fast-SENC cardiac magnetic resonance imaging
Tomas Lapinskas et al.
SCIENTIFIC REPORTS (2019)
Hypertension in the Cardio-Oncology Clinic
Lauren J. Hassen et al.
HEART FAILURE CLINICS (2019)
A Changing Landscape of Mortality for Systemic Light Chain Amyloidosis
Christopher D. Barrett et al.
JACC-HEART FAILURE (2019)
Role of physical therapy pre and post hematopoietic stem cell transplantation – White paper report
Jaleel Mohammed et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
How I treat cancer-associated venous thromboembolism
Noemie Kraaijpoel et al.
BLOOD (2019)
Grading cardiac response in AL amyloidosis: implications for relapse and survival
Erik Eckhert et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Cardioprotective Effect of Statins in Patients With HER2-Positive Breast Cancer Receiving Trastuzumab Therapy
Oscar Calvillo-Arguelles et al.
CANADIAN JOURNAL OF CARDIOLOGY (2019)
Test-retest reliability of new and conventional echocardiographic parameters of left ventricular systolic function
Tomasz Baron et al.
CLINICAL RESEARCH IN CARDIOLOGY (2019)
Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States
Jessica E. Potts et al.
EUROPEAN HEART JOURNAL (2019)
Atrial fibrillation in patients with active malignancy and use of anticoagulants: Under-prescription but no adverse impact on all-cause mortality
Vincenzo Livio Malavasi et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2019)
Protective role of beta-blockers in chemotherapy-induced cardiotoxicitya systematic review and meta-analysis of carvedilol
Shan Huang et al.
HEART FAILURE REVIEWS (2019)
Diabetes and Metabolic Syndrome in Survivors of Childhood Cancer
Danielle Novetsky Friedman et al.
HORMONE RESEARCH IN PAEDIATRICS (2019)
Radiation Dose-Response for Risk of Myocardial Infarction in Breast Cancer Survivors
Judy N. Jacobse et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Transcatheter Aortic Valve Replacement in Oncology Patients With Severe Aortic Stenosis
Uri Landes et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2019)
Effect of Rosuvastatin in Preventing Chemotherapy-Induced Cardiotoxicity in Women With Breast Cancer: A Randomized, Single-Blind, Placebo-Controlled Trial
Maryam Nabati et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2019)
Echocardiographic Assessment for the Detection of Cardiotoxicity Due to Vascular Endothelial Growth Factor Inhibitor Therapy in Metastatic Renal Cell and Colorectal Cancers
Lara F. Nhola et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2019)
Improving outcome of valve replacement for carcinoid heart disease
Anita Nguyen et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2019)
Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
Marc Carrier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)
Raza M. Alvi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors
Nicolas Palaskas et al.
AMERICAN JOURNAL OF CARDIOLOGY (2019)
Takotsubo cardiomyopathy in cancer patients
Aakash Desai et al.
CARDIO-ONCOLOGY (2019)
Carcinoid heart disease involving the left heart: a case report and biomarker analysis
Michael Lichtenauer et al.
ESC HEART FAILURE (2019)
Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis
Kathleen W. Zhang et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2019)
AL Amyloidosis for the Cardiologist and Oncologist Epidemiology, Diagnosis, and Management
Ronald M. Witteles et al.
JACC: CARDIOONCOLOGY (2019)
Efficacy of Neurohormonal Therapies in Preventing Cardiotoxicity in Patients With Cancer Undergoing Chemotherapy
Muthiah Vaduganathan et al.
JACC: CARDIOONCOLOGY (2019)
Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer
Ariane V. S. Macedo et al.
JACC: CARDIOONCOLOGY (2019)
Safety of Continuing Trastuzumab Despite Mild Cardiotoxicity A Phase I Trial
Darryl P. Leong et al.
JACC: CARDIOONCOLOGY (2019)
Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKETAF
Sean T. Chen et al.
EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2019)
Tumoral pulmonary hypertension
Laura C. Price et al.
EUROPEAN RESPIRATORY REVIEW (2019)
Ischemia and Bleeding in Cancer Patients Undergoing Percutaneous Coronary Intervention
Yasushi Ueki et al.
JACC: CARDIOONCOLOGY (2019)
Symptomatic Heart Failure in Acute Leukemia Patients Treated With Anthracyclines
Yu Kang et al.
JACC: CARDIOONCOLOGY (2019)
Osimertinib-Induced Cardiotoxicity A Retrospective Review of the FDA Adverse Events Reporting System (FAERS)
Kartik Anand et al.
JACC: CARDIOONCOLOGY (2019)
Cardiovascular Adverse Events Associated With BRAF and MEK Inhibitors A Systematic Review and Meta-analysis
Raluca I. Mincu et al.
JAMA NETWORK OPEN (2019)
Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy
Hanny Al-Samkari et al.
BLOOD ADVANCES (2019)
Recent Advances in the Diagnosis, Risk Stratification, and Management of Systemic Light-Chain Amyloidosis
Iuliana Vaxman et al.
ACTA HAEMATOLOGICA (2019)
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
Marco Valgimigli et al.
EUROPEAN HEART JOURNAL (2018)
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience
Alessandra Fornaro et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Sana M. Al-Khatib et al.
HEART RHYTHM (2018)
Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor-Associated Hypertension and Vascular Disease
Arvind K. Pandey et al.
HYPERTENSION (2018)
Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysis
Hadar Goldvaser et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Cardio-oncology in multiple myeloma: is it time for a specific focus?
Salvatrice Mancuso et al.
LEUKEMIA & LYMPHOMA (2018)
Primary thromboembolic prevention in multiple myeloma patients: An exploratory meta-analysis on aspirin use
Giacomo Zoppellaro et al.
SEMINARS IN HEMATOLOGY (2018)
A hospital and home-based exercise program to address functional decline in people following allogeneic stem cell transplantation
S. Abo et al.
SUPPORTIVE CARE IN CANCER (2018)
Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysis
Hadar Goldvaser et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancer
Chandrasekar Durairaj et al.
ANTI-CANCER DRUGS (2018)
Effects of high-intensity interval training on fatigue and quality of life in testicular cancer survivors
Scott C. Adams et al.
BRITISH JOURNAL OF CANCER (2018)
Optimising outcomes for patients with chronic lymphocytic leukaemia on ibrutinib therapy: European recommendations for clinical practice
John G. Gribben et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Management of QT prolongation induced by anti-cancer drugs: Target therapy and old agents. Different algorithms for different drugs
Carmela Coppola et al.
CANCER TREATMENT REVIEWS (2018)
Ability of Nonstrain Diastolic Parameters to Predict Doxorubicin-Induced Cardiomyopathy: A Systematic Review With Meta-Analysis
Mohamed Nagiub et al.
CARDIOLOGY IN REVIEW (2018)
Exercise Therapy and Cardiovascular Toxicity in Cancer
Jessica M. Scott et al.
CIRCULATION (2018)
Hypogonadism as a Reversible Cause of Torsades de Pointes in Men
Joe-Elie Salem et al.
CIRCULATION (2018)
Novel heart failure biomarkers: why do we fail to exploit their potential?
Arnold Piek et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2018)
International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology
Jelena-Rima Ghadri et al.
EUROPEAN HEART JOURNAL (2018)
International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management
Jelena-Rima Ghadri et al.
EUROPEAN HEART JOURNAL (2018)
Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial
Daniela Cardinale et al.
EUROPEAN JOURNAL OF CANCER (2018)
Long-term effect of epirubicin on incidence of heart failure in women with breast cancer: insight from a randomized clinical trial
Ann Banke et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge
Pietro Ameri et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects
Mariana Brandao et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
How to prevent and manage radiation-induced coronary artery disease
Jason R. Cuomo et al.
HEART (2018)
Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleeding
Giuseppe Boriani et al.
HEMATOLOGICAL ONCOLOGY (2018)
Management of patients with cardiac implantable electronic devices (CIED) undergoing radiotherapy A consensus document from Associazione Italiana Aritmologia e Cardiostimolazione (AIAC), Associazione Italiana Radioterapia Oncologica (AIRO), Associazione Italiana Fisica Medica (AIFM)
Massimo Zecchin et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Mechanism and management of cancer-associated thrombosis
Mikio Mukai et al.
JOURNAL OF CARDIOLOGY (2018)
Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3
Dennis J. Slamon et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Association of Cardiovascular Risk Factors With Cardiac Events and Survival Outcomes Among Patients With Breast Cancer Enrolled in SWOG Clinical Trials
Dawn L. Hershman et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Cardiovascular Disease in Survivors of Childhood Cancer: Insights Into Epidemiology, Pathophysiology, and Prevention
Saro H. Armenian et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Efficacy of Exercise Therapy on Cardiorespiratory Fitness in Patients With Cancer: A Systematic Review and Meta-Analysis
Jessica M. Scott et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
Annie M. Young et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Julie R. Brahmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Elevated Cardiac Troponin T in Patients With Skeletal Myopathies
Johannes Schmid et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity
Monica Samuel Avila et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Neoplasia and the Heart Pathological Review of Effects With Clinical and Radiological Correlation
Joseph J. Maleszewski et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
Syed S. Mahmood et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Clinical Applications of Ultrasonic Enhancing Agents in Echocardiography: 2018 American Society of Echocardiography Guidelines Update
Thomas R. Porter et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2018)
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
Debu Tripathy et al.
LANCET ONCOLOGY (2018)
Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity
Nikoletta Lendvai et al.
LEUKEMIA & LYMPHOMA (2018)
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
Gary E. Raskob et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The risk of carotid stenosis in head and neck cancer patients after radiation therapy
David J. Carpenter et al.
ORAL ONCOLOGY (2018)
Anticancer drug-induced cardiac rhythm disorders: Current knowledge and basic underlying mechanisms
Joachim Alexandre et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Cardiotoxicity mechanisms of the combination of BRAF-inhibitors and MEK-inhibitors
Enrico Bronte et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Coronary Toxicities of Anti-PD-1 and Anti-PD-L1 Immunotherapies: a Case Report and Review of the Literature and International Registries
Marion Ferreira et al.
TARGETED ONCOLOGY (2018)
Abnormalities in 3-Dimensional Left Ventricular Mechanics With Anthracycline Chemotherapy Are Associated With Systolic and Diastolic Dysfunction
Kathleen W. Zhang et al.
JACC-CARDIOVASCULAR IMAGING (2018)
Effect of Traditional Heart Failure Risk Factors on Myocardial Dysfunction in Adult Survivors of Childhood Cancer
Mark T. Nolan et al.
JACC-CARDIOVASCULAR IMAGING (2018)
Single Versus Standard Multiview Assessment of Global Longitudinal Strain for the Diagnosis of Cardiotoxicity During Cancer Therapy
Paaladinesh Thavendiranathan et al.
JACC-CARDIOVASCULAR IMAGING (2018)
Exercise Training and Cardiovascular Health in Cancer Patients
Ray W. Squires et al.
CURRENT ONCOLOGY REPORTS (2018)
Is it feasible to conduct a randomised controlled trial of pretransplant exercise (prehabilitation) for patients with multiple myeloma awaiting autologous haematopoietic stem cell transplantation? Protocol for the PREeMPT study
Carol Keen et al.
BMJ OPEN (2018)
CHA2DS2-VASc score and risk of thromboembolism and bleeding in patients with atrial fibrillation and recent cancer
Maria D'Souza et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2018)
Carfilzomib-Associated Cardiovascular Adverse Events A Systematic Review and Meta-analysis
Adam J. Waxman et al.
JAMA ONCOLOGY (2018)
Association of Exercise With Mortality in Adult Survivors of Childhood Cancer
Jessica M. Scott et al.
JAMA ONCOLOGY (2018)
Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary
Charles A. Schiffer et al.
JOURNAL OF ONCOLOGY PRACTICE (2018)
Safety of Diagnostic and Therapeutic Cardiac Catheterization in Cancer Patients With Acute Coronary Syndrome and Chronic Thrombocytopenia
Cezar Iliescu et al.
AMERICAN JOURNAL OF CARDIOLOGY (2018)
Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines
Bouthaina Shbib Dabaja et al.
BLOOD (2018)
Antithrombotic Therapy for Atrial Fibrillation CHEST Guideline and Expert Panel Report
Gregory Y. H. Lip et al.
CHEST (2018)
Immune Checkpoint Inhibitor-Associated Myositis: Expanding the Spectrum of Cardiac Complications of the Immunotherapy Revolution
Celine Anquetil et al.
CIRCULATION (2018)
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams et al.
EUROPEAN HEART JOURNAL (2018)
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy
Vera Regitz-Zagrosek et al.
EUROPEAN HEART JOURNAL (2018)
Activity and outcomes of a cardio-oncology service in the United Kingdom-a five-year experience
Nilesh Pareek et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Irreversible proteasome inhibition with carfilzomib as first line therapy in patients with newly diagnosed multiple myeloma: Early in vivo cardiovascular effects
Mara Gavazzoni et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Immune checkpoint inhibitors and cardiovascular toxicity
Alexander R. Lyon et al.
LANCET ONCOLOGY (2018)
Quality of Care in the United Kingdom after Removal of Financial Incentives
Mark Minchin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Multi-Modality Imaging in the Assessment of Cardiovascular Toxicity in the Cancer Patient
Juan Carlos Plana et al.
JACC-CARDIOVASCULAR IMAGING (2018)
Plasma levels of heart failure biomarkers are primarily a reflection of extracardiac production
Weijie Du et al.
THERANOSTICS (2018)
Long-term risk of cardiovascular mortality in lymphoma survivors: A systematic review and meta-analysis
Devon J. Boyne et al.
CANCER MEDICINE (2018)
1388PIncidence of cardiac toxicities in patients with advanced non-small cell lung cancer treated with osimertinib: A combined analysis of two phase III randomized controlled trials
K Z Thein et al.
ANNALS OF ONCOLOGY (2018)
Cytokine Release Syndrome with Chimeric Antigen Receptor T Cell Therapy
Noelle Frey et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Venous thromboembolism in multiple myeloma - choice of prophylaxis, role of direct oral anticoagulants and special considerations
Dawn Swan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Risk assessment of venous thromboembolism and thromboprophylaxis in pregnant women hospitalized with cancer: Preliminary results from a risk score
Eliane Azeka Hase et al.
CLINICS (2018)
Innovative imaging methods in heart failure: a shifting paradigm in cardiac assessment. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology
Jelena Celutkiene et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Risk of Thromboembolism Associated With Atrial Fibrillation Following Noncardiac Surgery
Jawad H. Butt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation Expert Recommendations
Vanessa M. Ferreira et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Cardiorespiratory Fitness and Mortality in Healthy Men and Women
Mary T. Imboden et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
2018 ESC/EACTS Guidelines on myocardial revascularization
Franz-Josef Neumann et al.
KARDIOLOGIA POLSKA (2018)
Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
Joe-Elie Salem et al.
LANCET ONCOLOGY (2018)
Two cases of lobectomy for lung cancer after transcatheter aortic valve implantation
Hideki Nagata et al.
SURGICAL CASE REPORTS (2018)
5-fluorouracil and cardiotoxicity: a review
Jaskanwal D. Sara et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Conservative management of nivolumab-induced pericardial effusion: a case report and review of literature
Shagufta Shaheen et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2018)
Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a BIeeMACS substudy
Mario Iannaccone et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2018)
Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation
Surbhi Shah et al.
BLOOD ADVANCES (2018)
Prediction of cardiovascular disease among hematopoietic cell transplantation survivors
Saro H. Armenian et al.
BLOOD ADVANCES (2018)
Analysis of carfilzomib cardiovascular safety profile across relapsed and/or refractory multiple myeloma clinical trials
Ajai Chari et al.
BLOOD ADVANCES (2018)
Left atrial abnormality (LAA) as a predictor of ibrutinib-associated atrial fibrillation in patients with chronic lymphocytic leukemia
Anthony R. Mato et al.
CANCER BIOLOGY & THERAPY (2018)
Recurrent cardiotoxicity potentiated by the interaction of proteasome inhibitor and immunomodulatory therapy for the treatment of multiple myeloma
Michael G. Fradley et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Diagnostic yield of cytopathology in evaluating pericardial effusions: Clinicopathologic analysis of 419 specimens
Jad Saab et al.
CANCER CYTOPATHOLOGY (2017)
Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL)
Tait D. Shanafelt et al.
LEUKEMIA & LYMPHOMA (2017)
Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis
Francesco Salinaro et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2017)
2017 ESC/EACTS Guidelines for the management of valvular heart disease The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
Helmut Baumgartner et al.
EUROPEAN HEART JOURNAL (2017)
Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer: A retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer Group
Johannes J. M. Kwakman et al.
EUROPEAN JOURNAL OF CANCER (2017)
Breast cancer treatment-induced cardiotoxicity
Samuel Martel et al.
EXPERT OPINION ON DRUG SAFETY (2017)
The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association
Daniel E. Freedberg et al.
GASTROENTEROLOGY (2017)
Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response
Martha Grogan et al.
HEART (2017)
2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices
Julia H. Indik et al.
HEART RHYTHM (2017)
Prevalence of cancer in Takotsubo cardiomyopathy: Short and long-term outcome
K. Sattler et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Incidence and Predictors of Pericardial Effusion After Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer
Matthew S. Ning et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Cardioprotective Effects of Carvedilol in Inhibiting Doxorubicin-induced Cardiotoxicity
Maryam Nabati et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2017)
Preexisting Cardiovascular Risk and Subsequent Heart Failure Among Non-Hodgkin Lymphoma Survivors
Talya Salz et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome
Matthew H. Kulke et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials
Carolyn Taylor et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Role of Troponins I and T and N-Terminal Prohormone of Brain Natriuretic Peptide in Monitoring Cardiac Safety of Patients With Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Trastuzumab: A Herceptin Adjuvant Study Cardiac Marker Substudy
Dimitrios Zardavas et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101-Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity
Edith Pituskin et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
Saro H. Armenian et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Cardiovascular Complications of Cancer Therapy Best Practices in Diagnosis, Prevention, and Management: Part 2
Hui-Ming Chang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Diagnosing and Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors An Expert Statement
Joseph Davar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Cardiac Outcomes With Pregnancy After Cardiotoxic Therapy for Childhood Cancer
Kara A. Thompson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Risk of Arterial Thromboembolism in Patients With Cancer
Babak B. Navi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial
David Cameron et al.
LANCET (2017)
Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study
Daniel M. Halperin et al.
LANCET ONCOLOGY (2017)
Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site
E. Hadzijusufovic et al.
LEUKEMIA (2017)
Reference Standards for Cardiorespiratory Fitness Measured With Cardiopulmonary Exercise Testing Using Cycle Ergometry: Data From the Fitness Registry and the Importance of Exercise National Database (FRIEND) Registry
Leonard A. Kaminsky et al.
MAYO CLINIC PROCEEDINGS (2017)
A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study
Grigoris T. Gerotziafas et al.
ONCOLOGIST (2017)
Cardio-Onco-Hematología en la práctica clínica. Documento de consenso y recomendaciones
Teresa López-Fernández et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2017)
Nuevas técnicas de imagen cardiaca en la detección precoz de cardiotoxicidad secundaria a tratamientos oncológicos
Teresa López-Fernández et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2017)
Tinzaparin in cancer associated thrombosis beyond 6 months: TiCAT study
Luis Jara-Palomares et al.
THROMBOSIS RESEARCH (2017)
Encouraging impact of doxycycline on early mortality in cardiac light chain (AL) amyloidosis
A. D. Wechalekar et al.
BLOOD CANCER JOURNAL (2017)
2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancer patients: a balance with feasibility
Ciro Santoro et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2017)
Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging
Maurizio Galderisi et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2017)
Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study
Geeta Gulati et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review
Andreu Porta-Sanchez et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
High-sensitive cardiac troponin-I facilitates timely detection of subclinical anthracycline-mediated cardiac injury
Melissa Jones et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2017)
Cardiovascular and Thrombotic Complications of Novel Multiple Myeloma Therapies A Review
Weijuan Li et al.
JAMA ONCOLOGY (2017)
Temporal trends and outcomes of acute myocardial infarction in patients with cancer
Naga Venkata Pothineni et al.
ANNALS OF TRANSLATIONAL MEDICINE (2017)
Cardiovascular care of patients with chronic myeloid leukemia (CML) on tyrosine kinase inhibitor (TKI) therapy
Mary C. Barber et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2017)
Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE Trial
Chiara Melloni et al.
AMERICAN JOURNAL OF MEDICINE (2017)
Bringing on the light in a complex clinical scenario: Optical coherence tomographyguided discontinuation of antiplatelet therapy in cancer patients with coronary artery disease (PROTECT-OCT registry)
Cezar A. Iliescu et al.
AMERICAN HEART JOURNAL (2017)
Blood Pressure Status in Adult Survivors of Childhood Cancer: A Report from the St. Jude Lifetime Cohort Study
Todd M. Gibson et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Cardiovascular Effects of the MEK Inhibitor, Trametinib: A Case Report, Literature Review, and Consideration of Mechanism
Mary Banks et al.
CARDIOVASCULAR TOXICOLOGY (2017)
Effect of Degarelix, a Gonadotropin-Releasing Hormone Receptor Antagonist for the Treatment of Prostate Cancer, on Cardiac Repolarisation in a Randomised, Placebo and Active Comparator Controlled Thorough QT/QTc Trial in Healthy Men
Hakan Olsson et al.
CLINICAL DRUG INVESTIGATION (2017)
US Food and Drug Administration Approval Summary: Atezolizumab for Metastatic Non-Small Cell Lung Cancer
Chana Weinstock et al.
CLINICAL CANCER RESEARCH (2017)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
Clyde W. Yancy et al.
CIRCULATION (2017)
Cancer Treatment-Induced Arrhythmias Focus on Chemotherapy and Targeted Therapies
Vitaly Buza et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2017)
Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease
Meera Mohan et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Trastuzumab-induced cardiotoxicity: testing a clinical risk score in a real-world cardio-oncology population
M. Rushton et al.
CURRENT ONCOLOGY (2017)
Angiotensin Inhibitors as Treatment of Sunitinib/Pazopanib-induced Hypertension in Metastatic Renal Cell Carcinoma
Patrick Penttila et al.
CLINICAL GENITOURINARY CANCER (2017)
Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure A Scientific Statement From the American Heart Association
Sheryl L. Chow et al.
CIRCULATION (2017)
Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade
Thilo Gambichler et al.
BMC CANCER (2017)
Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis
Mathew S. Maurer et al.
CIRCULATION (2017)
Accuracy of left ventricular ejection fraction by contemporary multiple gated acquisition scanning in patients with cancer: comparison with cardiovascular magnetic resonance
Hans Huang et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2017)
Population-Based Long-Term Cardiac-Specific Mortality Among 34 489 Five-Year Survivors of Childhood Cancer in Great Britain
Miranda M. Fidler et al.
CIRCULATION (2017)
Cardiovascular toxicity of angiogenesis inhibitors in treatment of malignancy: A systematic review and meta-analysis
Husam Abdel-Qadir et al.
CANCER TREATMENT REVIEWS (2017)
Radiotherapy in patients with pacemakers and implantable cardioverter defibrillators: a literature review
Tomas Zaremba et al.
EUROPACE (2016)
'Real-life' experience of preapproval carfilzomib-based therapy in myeloma - analysis of cardiac toxicity and predisposing factors
Sophia Danhof et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
Current state of knowledge on Takotsubo syndrome: a position statement from the task force on Takotsubo syndrome of the Heart Failure Association of the European Society of Cardiology
Alexander R. Lyon et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Radiation-induced valvular heart disease
Dorothy M. Gujral et al.
HEART (2016)
Analysis of outcomes of percutaneous coronary intervention in metastatic cancer patients with acute coronary syndrome over a 10-year period
Achuta Kumar Guddati et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
Deep inspiration breath-hold volumetric modulated arc radiotherapy decreases dose to mediastinal structures in locally advanced lung cancer
Gitte F. Persson et al.
ACTA ONCOLOGICA (2016)
Cause and Long-Term Outcome of Cardiac Tamponade
Cristina Sanchez-Enrique et al.
AMERICAN JOURNAL OF CARDIOLOGY (2016)
Comparison of Results of Transcatheter Aortic Valve Implantation in Patients With Versus Without Active Cancer
Yusuke Watanabe et al.
AMERICAN JOURNAL OF CARDIOLOGY (2016)
Left Ventricular Dysfunction After Treatment With Ipilimumab for Metastatic Melanoma
Mary E. Roth et al.
AMERICAN JOURNAL OF THERAPEUTICS (2016)
SCAI Expert consensus statement: Evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory (endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologa intervencionista)
Cezar A. Iliescu et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2016)
Vascular Toxicities of Cancer Therapies The Old and the New - An Evolving Avenue
Joerg Herrmann et al.
CIRCULATION (2016)
Shared Risk Factors in Cardiovascular Disease and Cancer
Ryan J. Koene et al.
CIRCULATION (2016)
Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign A Scientific Statement From the American Heart Association
Robert Ross et al.
CIRCULATION (2016)
Cardio-Oncology An Update on Cardiotoxicity of Cancer-Related Treatment
Carrie G. Lenneman et al.
CIRCULATION RESEARCH (2016)
Baseline Immunoglobulin E Levels as a Marker of Doxorubicin- and Trastuzumab-Associated Cardiac Dysfunction
Lynn A. Beer et al.
CIRCULATION RESEARCH (2016)
Long-Term Mortality in Patients With Radiation-Associated Coronary Artery Disease Treated With Percutaneous Coronary Intervention
Grant W. Reed et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2016)
Radiation-induced heart disease: A practical guide to diagnosis and management
Eoin Donnellan et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2016)
It's PRIMETIME. Postoperative Avoidance of Radiotherapy: Biomarker Selection of Women at Very Low Risk of Local Recurrence
C. C. Kirwan et al.
CLINICAL ONCOLOGY (2016)
Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 x 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
Geeta Gulati et al.
EUROPEAN HEART JOURNAL (2016)
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
Jose Luis Zamorano et al.
EUROPEAN HEART JOURNAL (2016)
Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy
Yong-Joon Lee et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
The Utility of Point-of-Care Biomarkers to Detect Cardiotoxicity During Anthracycline Chemotherapy: A Feasibility Study
Daniel J. Lenihan et al.
JOURNAL OF CARDIAC FAILURE (2016)
Incidence rate of primary cardiac tumors: a 14-year population study
Alberto Cresti et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2016)
Statins Are Associated With Reduced Mortality in Multiple Myeloma
Kristen Marie Sanfilippo et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Long-Term Cardiac Safety Analysis of NCCTG N9831 (Alliance) Adjuvant Trastuzumab Trial
Pooja P. Advani et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma
Frederika A. van Nimwegen et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Predicting drug-induced QT prolongation and torsades de pointes
Dan M. Roden
JOURNAL OF PHYSIOLOGY-LONDON (2016)
The Utility of Exercise Testing in Patients with Lung Cancer
Duc Ha et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
The 2015 WHO Classification of Tumors of the Heart and Pericardium
Allen Burke et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
Massimo Cristofanilli et al.
LANCET ONCOLOGY (2016)
Ibrutinib-related atrial fibrillation in patients with mantle cell lymphoma
Hun Ju Lee et al.
LEUKEMIA & LYMPHOMA (2016)
Impact of dose intensity of ponatinib on selected adverse events: Multivariate analyses from a pooled population of clinical trial patients
David J. Dorer et al.
LEUKEMIA RESEARCH (2016)
Prevalence of Preexisting Cardiovascular Disease in Patients With Different Types of Cancer: The Unmet Need for Onco-Cardiology
Sadeer G. Al-Kindi et al.
MAYO CLINIC PROCEEDINGS (2016)
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Douglas B. dbj Johnson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Cardiovascular Toxic Effects of Targeted Cancer Therapies
Javid J. Moslehi
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
G. N. Hortobagyi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Palbociclib and Letrozole in Advanced Breast Cancer
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Influence of steroid hormones on ventricular repolarization
Joe-Elie Salem et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Predictors of recurrent venous thromboembolism and bleeding on anticoagulation
Laurel A. Menapace et al.
THROMBOSIS RESEARCH (2016)
Cost-effectiveness analysis of low-molecular-weight heparin versus aspirin thromboprophylaxis in patients newly diagnosed with multiple myeloma
Emilie Chalayer et al.
THROMBOSIS RESEARCH (2016)
Epidemiology of venous thromboembolism in the Framingham Heart Study
Marja K. Puurunen et al.
THROMBOSIS RESEARCH (2016)
Noninvasive Measures of Ventricular-Arterial Coupling and Circumferential Strain Predict Cancer Therapeutics-Related Cardiac Dysfunction
Hari K. Narayan et al.
JACC-CARDIOVASCULAR IMAGING (2016)
Cardiotoxicity as indicated by LVEF and troponin T sensitivity following two anthracycline-based regimens in lymphoma: Results from a randomized prospective clinical trial
Kai Xue et al.
ONCOTARGET (2016)
Association Between Life's Simple 7 and Noncardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis
Oluseye Ogunmoroti et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Which QT Correction Formulae to Use for QT Monitoring?
Bert Vandenberk et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Arrhythmias and Other Electrophysiology Issues in Cancer Patients Receiving Chemotherapy or Radiation
Federico Viganego et al.
CURRENT CARDIOLOGY REPORTS (2016)
Echocardiography in Pregnancy: Part 2
Meena Narayanan et al.
CURRENT CARDIOLOGY REPORTS (2016)
Angiotensin II-Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer A Randomized Clinical Trial
Annelies H. Boekhout et al.
JAMA ONCOLOGY (2016)
Major Cardiac Events and the Value of Echocardiographic Evaluation in Patients Receiving Anthracycline-Based Chemotherapy
Lin Wang et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
Chemotherapy-Induced Pulmonary Hypertension Role of Alkylating Agents
Benoit Ranchoux et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
ErbB2 overexpression upregulates antioxidant enzymes, reduces basal levels of reactive oxygen species, and protects against doxorubicin cardiotoxicity
Frances Belmonte et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2015)
Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma
H. Izzedine et al.
ANNALS OF ONCOLOGY (2015)
Arrhythmias in the setting of hematopoietic cell transplants
E. S. Tonorezos et al.
BONE MARROW TRANSPLANTATION (2015)
Chronic Statin Administration May Attenuate Early Anthracycline-Associated Declines in Left Ventricular Ejection Function
Runyawan Chotenimitkhun et al.
CANADIAN JOURNAL OF CARDIOLOGY (2015)
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
Daniela Cardinale et al.
CIRCULATION (2015)
Angiotensin System Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma
Rana R. McKay et al.
CLINICAL CANCER RESEARCH (2015)
Congestive heart failure with vascular endothelial growth factor receptor tyrosine kinase inhibitors
Pooja Ghatalia et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
Cancer Chemotherapy and Cardiac Arrhythmias: A Review
Juan Tamargo et al.
DRUG SAFETY (2015)
2015 ESC Guidelines for the diagnosis and management of pericardial diseases The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)
Yehuda Adler et al.
EUROPEAN HEART JOURNAL (2015)
Comparison of cardiac events associated with liposomal doxorubicin, epirubicin and doxorubicin in breast cancer: a Bayesian network meta-analysis
Norihiro Yamaguchi et al.
EUROPEAN JOURNAL OF CANCER (2015)
State of the Art: Newer biomarkers in heart failure
Rudolf A. de Boer et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality
Noemi Pavo et al.
HEART (2015)
Subclinical Carotid Atherosclerosis and Early Vascular Aging From Long-Term Low-Dose Ionizing Radiation Exposure A Genetic, Telomere, and Vascular Ultrasound Study in Cardiac Catheterization Laboratory Staff
Maria Grazia Andreassi et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2015)
Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer A Randomized Clinical Trial
Agnes Y. Y. Lee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Pulmonary Vein Isolation for Atrial Fibrillation in the Postpneumonectomy Population: A Feasibility, Safety, and Outcomes Study
Arun Kanmanthareddy et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2015)
Tyrosine Kinase Inhibitor-Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia
Javid J. Moslehi et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Vascular and Metabolic Implications of Novel Targeted Cancer Therapies Focus on Kinase Inhibitors
Weijuan Li et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Early and Late Outcomes of Surgical Treatment in Carcinoid Heart Disease
Heidi M. Connolly et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Cardiovascular Health of Patients With Cancer and Cancer Survivors A Roadmap to the Next Level
Ana Barac et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Time Trends of Left Ventricular Ejection Fraction and Myocardial Deformation Indices in a Cohort of Women with Breast Cancer Treated with Anthracyclines, Taxanes, and Trastuzumab
Timothy C. Tan et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2015)
Head-to-Head Comparison of Global Longitudinal Strain Measurements among Nine Different Vendors The EACVI/ASE Inter-Vendor Comparison Study
Konstantinos E. Farsalinos et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2015)
Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma
David J. Cutter et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12months: the DALTECAN Study
C. W. Francis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial
Georgina V. Long et al.
LANCET (2015)
Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial
Ian H. Kunkler et al.
LANCET ONCOLOGY (2015)
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
Saro H. Armenian et al.
LANCET ONCOLOGY (2015)
A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer
Folefac Aminkeng et al.
NATURE GENETICS (2015)
Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin's Lymphoma
John Radford et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
A. Keith Stewart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Risk of Device Malfunction in Cancer Patients with Implantable Cardiac Device Undergoing Radiotherapy: A Population-Based Cohort Study
Tomas Zaremba et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2015)
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Roberto M. Lang et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2015)
Self-Reported Cardiorespiratory Fitness: Prediction and Classification of Risk of Cardiovascular Disease Mortality and Longevity-A Prospective Investigation in the Copenhagen City Heart Study
Andreas Holtermann et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
A framework for prescription in exercise-oncology research
John P. Sasso et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2015)
Cardiovascular Disease After Hodgkin Lymphoma Treatment 40-Year Disease Risk
Frederika A. van Nimwegen et al.
JAMA INTERNAL MEDICINE (2015)
Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma
David J. Cutter et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Radiotherapy-Induced Malfunction in Contemporary Cardiovascular Implantable Electronic Devices Clinical Incidence and Predictors
Jonathan D. Grant et al.
JAMA ONCOLOGY (2015)
Cardiorespiratory fitness as predictor of cancer mortality: a systematic review and meta-analysis
D. Schmid et al.
ANNALS OF ONCOLOGY (2015)
Phase 2 study of carfilzomib, thalidomide, and dexamethasone as induction/consolidation therapy for newly diagnosed multiple myeloma
Pieter Sonneveld et al.
BLOOD (2015)
Vascular safety issues in CML patients treated with BCR/ABL1 kinase inhibitors
Peter Valent et al.
BLOOD (2015)
QTc interval prolongation with vascular endothelial growth factor receptor tyrosine kinase inhibitors
P. Ghatalia et al.
BRITISH JOURNAL OF CANCER (2015)
Clinical Risk Factors for the Development of Hypertension in Patients Treated With Inhibitors of the VEGF Signaling Pathway
Ole-Petter R. Hamnvik et al.
CANCER (2015)
Protective effects of spironolactone against anthracycline-induced cardiomyopathy
Mahmut Akpek et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Development and Evaluation of an Educational E-Tool to Help Patients With Non-Hodgkin's Lymphoma Manage Their Personal Care Pathway
Jozette J. C. Stienen et al.
JMIR RESEARCH PROTOCOLS (2015)
Ibrutinib increases the risk of atrial fibrillation, potentially through inhibition of cardiac PI3K-Akt signaling
Julie R. McMullen et al.
BLOOD (2014)
Cardiopulmonary exercise variables are associated with postoperative morbidity after major colonic surgery: a prospective blinded observational study
M. A. West et al.
BRITISH JOURNAL OF ANAESTHESIA (2014)
Cardiopulmonary exercise testing for the prediction of morbidity risk after rectal cancer surgery
M. A. West et al.
BRITISH JOURNAL OF SURGERY (2014)
Prediction of 30-Year Risk for Cardiovascular Mortality by Fitness and Risk Factor Levels The Cooper Center Longitudinal Study
Chanaka D. Wickramasinghe et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2014)
Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction
Kashif Kalam et al.
HEART (2014)
The clinical presentation and management of carcinoid heart disease
R. Dobson et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Outcomes After Percutaneous Coronary Intervention With Stents in Patients Treated With Thoracic External Beam Radiation for Cancer
Jackson J. Liang et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2014)
Trastuzumab-Associated Cardiac Events at 8 Years of Median Follow-Up in the Herceptin Adjuvant Trial (BIG 1-01)
Evandro de Azambuja et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Exercise and Risk of Major Cardiovascular Events in Adult Survivors of Childhood Hodgkin Lymphoma: A Report From the Childhood Cancer Survivor Study
Lee W. Jones et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Incidence and risk-factors of CHOP/R-CHOP-related cardiotoxicity in patients with aggressive non-Hodgkin's lymphoma
S. Limat et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2014)
Use of Myocardial Strain Imaging by Echocardiography for the Early Detection of Cardiotoxicity in Patients During and After Cancer Chemotherapy
Paaladinesh Thavendiranathan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Insights Into Onco-Cardiology Atrial Fibrillation in Cancer
Dimitrios Farmakis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Prevention of Anthracycline-Induced Cardiotoxicity
Pimprapa Vejpongsa et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab
Bonnie Ky et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Analysis of Left Ventricular Volumes and Function: A Multicenter Comparison of Cardiac Magnetic Resonance Imaging, Cine Ventriculography, and Unenhanced and Contrast-Enhanced Two-Dimensional and Three-Dimensional Echocardiography
Rainer Hoffmann et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2014)
Pre-existing arterial hypertension as a risk factor for early left ventricular systolic dysfunction following (R)-CHOP chemotherapy in patients with lymphoma
Sebastian Szmit et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2014)
Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5-a population-based study
Gemma Gatta et al.
LANCET ONCOLOGY (2014)
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
S. K. Kumar et al.
LEUKEMIA (2014)
Evaluation and Management of Patients With Heart Disease and Cancer: Cardio-Oncology
Joerg Herrmann et al.
MAYO CLINIC PROCEEDINGS (2014)
Androgen Deprivation Therapy for Prostate Cancer Is Associated with Cardiovascular Morbidity and Mortality: A Meta-Analysis of Population-Based Observational Studies
Jinsheng Zhao et al.
PLOS ONE (2014)
Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection
Kazuaki Negishi et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2014)
Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Juan Carlos Plana et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2014)
Risk Prediction Model for Heart Failure and Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer
Ghideon Ezaz et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity
Anne Polk et al.
BMC PHARMACOLOGY & TOXICOLOGY (2014)
Cardiac Masses on Cardiac CT: A Review
David Kassop et al.
CURRENT CARDIOVASCULAR IMAGING REPORTS (2014)
Cardiovascular magnetic resonance in pregnancy: Insights from the cardiac hemodynamic imaging and remodeling in pregnancy (CHIRP) study
Robin A. Ducas et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2014)
Retrospective Comparison of Outcomes, Diagnostic Value, and Complications of Percutaneous Prolonged Drainage Versus Surgical Pericardiotomy of Pericardial Effusion Associated With Malignancy
Nimish Patel et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
Outcome After ST Elevation Myocardial Infarction in Patients With Cancer Treated With Primary Percutaneous Coronary Intervention
Matthijs A. Velders et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F. A. Peccatori et al.
ANNALS OF ONCOLOGY (2013)
Incidence of Supraventricular Arrhythmias during Autologous Peripheral Blood Stem Cell Transplantation
Abhishek Singla et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Phase 2 dose-expansion study (PX-171-006) of carfilzomib, lenalidomide, and low-dose dexamethasone in relapsed or progressive multiple myeloma
Michael Wang et al.
BLOOD (2013)
Systemic light chain amyloidosis: an update for treating physicians
Giampaolo Merlini et al.
BLOOD (2013)
Long-Term Survival of Patients With Radiation Heart Disease Undergoing Cardiac Surgery A Cohort Study
Willis Wu et al.
CIRCULATION (2013)
Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on Cardiac Repolarisation (QT Interval)
Rashmi R. Shah et al.
DRUG SAFETY (2013)
A non-exercise testing method for estimating cardiorespiratory fitness: associations with all-cause and cardiovascular mortality in a pooled analysis of eight population-based cohorts
Emmanuel Stamatakis et al.
EUROPEAN HEART JOURNAL (2013)
2013 ESC guidelines on the management of stable coronary artery disease
Gilles Montalescot et al.
EUROPEAN HEART JOURNAL (2013)
Incidence of venous thromboembolism in patients with cancer - A cohort study using linked United Kingdom databases
Alex J. Walker et al.
EUROPEAN JOURNAL OF CANCER (2013)
Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: A systematic review and meta-analysis
Kashif Kalam et al.
EUROPEAN JOURNAL OF CANCER (2013)
Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studies
David Siegel et al.
HAEMATOLOGICA (2013)
Incident thromboembolism and heart failure associated with new-onset atrial fibrillation in cancer patients
Yu-feng Hu et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Malfunctions of Implantable Cardiac Devices in Patients Receiving Proton Beam Therapy: Incidence and Predictors
Daniel R. Gomez et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Modifiable Risk Factors and Major Cardiac Events Among Adult Survivors of Childhood Cancer
Gregory T. Armstrong et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies
Xavier Bosch et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Reproducibility of Echocardiographic Techniques for Sequential Assessment of Left Ventricular Ejection Fraction and Volumes Application to Patients Undergoing Cancer Chemotherapy
Paaladinesh Thavendiranathan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Expert Consensus for Multi-Modality Imaging Evaluation of Cardiovascular Complications of Radiotherapy in Adults: A Report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography
Patrizio Lancellotti et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2013)
Independent and Incremental Value of Deformation Indices for Prediction of Trastuzumab-Induced Cardiotoxicity
Kazuaki Negishi et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2013)
2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial
Aron Goldhirsch et al.
LANCET (2013)
Statin Use and Reduced Cancer-Related Mortality
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Mechanisms of Disease Proteotoxicity and Cardiac Dysfunction - Alzheimer's Disease of the Heart?
Monte S. Willis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
Sarah C. Darby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The Association of a Panel of Biomarkers with the Presence and Severity of Carcinoid Heart Disease: A Cross-Sectional Study
Rebecca Dobson et al.
PLOS ONE (2013)
Cardiovascular complications associated with novel angiogenesis inhibitors: Emerging evidence and evolving perspectives
Steven M. Bair et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2013)
Low to Moderate Dose Anthracycline-Based Chemotherapy Is Associated With Early Noninvasive Imaging Evidence of Subclinical Cardiovascular Disease
Brandon C. Drafts et al.
JACC-CARDIOVASCULAR IMAGING (2013)
Risk of first venous thromboembolism in pregnant women in hospital: population based cohort study from England
Alyshah Abdul Sultan et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors
Richard M. Steingart et al.
AMERICAN HEART JOURNAL (2012)
Capecitabine-Induced Chest Pain Relieved by Diltiazem
Andrew P. Ambrosy et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Best use of cardiac biomarkers in patients with AL amyloidosis and renal failure
Giovanni Palladini et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors
C. Serrano et al.
ANNALS OF ONCOLOGY (2012)
Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines
G. Curigliano et al.
ANNALS OF ONCOLOGY (2012)
Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide
Alessandra Larocca et al.
BLOOD (2012)
Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease
Saro H. Armenian et al.
BLOOD (2012)
Risk of first venous thromboembolism in and around pregnancy: a population-based cohort study
Alyshah Abdul Sultan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Nutrition and Physical Activity Guidelines for Cancer Survivors
Cheryl L. Rock et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Pulmonary Arterial Hypertension in Patients Treated by Dasatinib
David Montani et al.
CIRCULATION (2012)
Morphological and Functional Adaptation of the Maternal Heart During Pregnancy
Oana Savu et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2012)
Response to Treatment and Outcomes of Acute Coronary Syndrome in the Cancer Population
S. W. Yusuf et al.
CLINICAL CARDIOLOGY (2012)
Treatment and Outcomes of Acute Coronary Syndrome in the Cancer Population
Syed Wamique Yusuf et al.
CLINICAL CARDIOLOGY (2012)
Real Time Three-Dimensional Echocardiography Evaluation of Intracardiac Masses
Elisa Zaragosa-Macias et al.
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES (2012)
Changes in Cardiac Biomarkers During Doxorubicin Treatment of Pediatric Patients With High-Risk Acute Lymphoblastic Leukemia: Associations With Long-Term Echocardiographic Outcomes
Steven E. Lipshultz et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements
Shaji Kumar et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
Edward H. Romond et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Screening Adult Survivors of Childhood Cancer for Cardiomyopathy: Comparison of Echocardiography and Cardiac Magnetic Resonance Imaging
Gregory T. Armstrong et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes-A Report From the Children's Oncology Group
Javier G. Blanco et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Differentiation of Malignant and Benign Cardiac Tumors Using 18F-FDG PET/CT
Kambiz Rahbar et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Effect of Statin Therapy on the Risk for Incident Heart Failure in Patients With Breast Cancer Receiving Anthracycline Chemotherapy An Observational Clinical Cohort Study
Sinziana Seicean et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer
Jersey Chen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Performance of 3-Dimensional Echocardiography in Measuring Left Ventricular Volumes and Ejection Fraction
Jennifer L. Dorosz et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Late Cardiovascular Toxicity Following Chemotherapy for Germ Cell Tumors
Darren R. Feldman et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2012)
Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis
R. L. Comenzo et al.
LEUKEMIA (2012)
Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Incidence and Risk of QTc Interval Prolongation among Cancer Patients Treated with Vandetanib: A Systematic Review and Meta-analysis
Jiajie Zang et al.
PLOS ONE (2012)
Management of radiation oncology patients with a pacemaker or ICD: A new comprehensive practical guideline in The Netherlands
Coen W. Hurkmans et al.
RADIATION ONCOLOGY (2012)
Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis
Melanie Demers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
In patients with carcinoid syndrome undergoing valve replacement, will a biological valve have acceptable durability?
Nigel Mabvuure et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2012)
Updated evidence in support of diet and exercise interventions in cancer survivors
Dorothy W. Pekmezi et al.
ACTA ONCOLOGICA (2011)
Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML
Karl J. Aichberger et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Venous Thromboembolism in the Patient With Cancer Focus on Burden of Disease and Benefits of Thromboprophylaxis
Gary H. Lyman
CANCER (2011)
Effects of Novel Angiogenesis Inhibitors for the Treatment of Cancer on the Cardiovascular System
Babak Nazer et al.
CIRCULATION (2011)
Cardiorespiratory Fitness and Classification of Risk of Cardiovascular Disease Mortality
Sachin Gupta et al.
CIRCULATION (2011)
Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology
Thomas Eschenhagen et al.
EUROPEAN JOURNAL OF HEART FAILURE (2011)
Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: Effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide
Mauro Feola et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Risk of Recurrent Venous Thromboembolism and Mortality in Patients With Cancer Incidentally Diagnosed With Pulmonary Embolism: A Comparison With Symptomatic Patients
Paul L. den Exter et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial
Antonio Palumbo et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Efficiency of Atorvastatin in the Protection of Anthracycline-Induced Cardiomyopathy
Zeydin Acar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Characterization of Cardiac Tumors in Children by Cardiovascular Magnetic Resonance Imaging A Multicenter Experience
Rebecca S. Beroukhim et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Diseased Skeletal Muscle A Noncardiac Source of Increased Circulating Concentrations of Cardiac Troponin T
Allan S. Jaffe et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients: A Systematic Review and Meta-analysis
Eitan Amir et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Reversible Cardiomyopathy Associated with Sunitinib and Sorafenib
Imran Uraizee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Dennis Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Carcinoid heart disease: Case and literature review
Michiel Dumoulein et al.
ACTA CARDIOLOGICA (2010)
Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
Melinda Protani et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Features of Carcinoid Heart Disease Identified by 2-and 3-Dimensional Echocardiography and Cardiac MRI
Sanjeev Bhattacharyya et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2010)
RADIATION DOSE-VOLUME EFFECTS IN THE HEART
Giovanna Gagliardi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Energetics in Colorectal and Prostate Cancer
Jeffrey A. Meyerhardt et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Cardiovascular Risk Factors and Morbidity in Long-Term Survivors of Testicular Cancer: A 20-Year Follow-Up Study
Hege S. Haugnes et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Independent Adjudication of Symptomatic Heart Failure With the Use of Doxorubicin and Cyclophosphamide Followed by Trastuzumab Adjuvant Therapy: A Combined Review of Cardiac Data From the National Surgical Adjuvant Breast and Bowel Project B-31 and the North Central Cancer Treatment Group N9831 Clinical Trials
Stuart D. Russell et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Combined Resistance and Aerobic Exercise Program Reverses Muscle Loss in Men Undergoing Androgen Suppression Therapy for Prostate Cancer Without Bone Metastases: A Randomized Controlled Trial
Daniel A. Galvao et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Role of Three-Dimensional Echocardiography in Breast Cancer: Comparison With Two-Dimensional Echocardiography, Multiple-Gated Acquisition Scans, and Cardiac Magnetic Resonance Imaging
Jonathan Walker et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation
Daniela Cardinale et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Risk of Arterial Thromboembolic Events With Sunitinib and Sorafenib: A Systematic Review and Meta-Analysis of Clinical Trials
Toni K. Choueiri et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
B-Type Natriuretic Peptide in Pregnant Women With Heart Disease
David Tanous et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Anthracycline-Induced Cardiomyopathy Clinical Relevance and Response to Pharmacologic Therapy
Daniela Cardinale et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors
Michael L. Maitland et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients
S. Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
Hagop Kantarjian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis
Rebecca M. Speck et al.
JOURNAL OF CANCER SURVIVORSHIP (2010)
The Effects of Obesity and Obesity-Related Conditions on Colorectal Cancer Prognosis
Erin M. Siegel et al.
CANCER CONTROL (2010)
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis
G. Di Lorenzo et al.
ANNALS OF ONCOLOGY (2009)
Sunitinib Malate, a Receptor Tyrosine Kinase Inhibitor, Is Effective in the Treatment of Restrictive Heart Failure due to Heart Metastases from Renal Cell Carcinoma
Sebastian Szmit et al.
CARDIOLOGY (2009)
Intracardiac Thrombosis and Anticoagulation Therapy in Cardiac Amyloidosis
DaLi Feng et al.
CIRCULATION (2009)
Left ventricular volume measurement with echocardiography: a comparison of left ventricular opacification, three-dimensional echocardiography, or both with magnetic resonance imaging
Carly Jenkins et al.
EUROPEAN HEART JOURNAL (2009)
SYSTEMIC DISORDERS IN HEART DISEASE Radiation induced heart disease
Paul A. Heidenreich et al.
HEART (2009)
Dietary Patterns and Breast Cancer Recurrence and Survival Among Women With Early-Stage Breast Cancer
Marilyn L. Kwan et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants
Martee L. Hensley et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Assessing Risk of Venous Thromboembolism in the Patient With Cancer
Alok A. Khorana et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Predictors of Coronary Stent Thrombosis The Dutch Stent Thrombosis Registry
Jochem W. van Werkum et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Cardiovascular Complications of Cancer Therapy Incidence, Pathogenesis, Diagnosis, and Management
Edward T. H. Yeh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study
Giancarlo Agnelli et al.
LANCET ONCOLOGY (2009)
Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort
Daniel A. Mulrooney et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Usefulness of N-terminal pro-brain natriuretic peptide as a biomarker of the presence of carcinoid heart disease
Sanjeev Bhattacharyya et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Development and validation of a predictive model for chemotherapy-associated thrombosis
Alok A. Khorana et al.
BLOOD (2008)
Heart failure associated with sunitinib malate - A multitargeted receptor tyrosine kinase inhibitor
Aarif Y. Khakoo et al.
CANCER (2008)
Drug-induced QTc interval prolongation: A proposal towards an efficient and safe anticancer drug development
Giuseppe Curigliano et al.
EUROPEAN JOURNAL OF CANCER (2008)
Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy
Xiong Wei et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: Findings from cancer and leukemia group B 89803
Jeffrey A. Meyerhardt et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma
Dawn L. Hershman et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Home blood-pressure monitoring in patients receiving sunitinib
Michel Azizi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
A. Palumbo et al.
LEUKEMIA (2008)
The development of a predictive model to estimate cardiotoxic risk for patients with metastatic breast cancer receiving anthracyclines
George Dranitsaris et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
Tammy F. Chu et al.
LANCET (2007)
Carcinoid heart disease
Sanjeev Bhattacharyya et al.
CIRCULATION (2007)
Innovations in image-guided radiotherapy
Dirk Verellen et al.
NATURE REVIEWS CANCER (2007)
Intracardiac thrombosis and embolism in patients with cardiac amyloidosis
DaLi Feng et al.
CIRCULATION (2007)
Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation
Andre Tichelli et al.
BLOOD (2007)
Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer
Mary C. Pinder et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer
Jeffrey A. Meyerhardt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Medical assessment of adverse health outcomes in long-term survivors of childhood cancer
Maud M. Geenen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Trastuzumab treatment and the risk of central nervous system (CNS) metastases
M. C. Pinder et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality
Margaret E. Wright et al.
CANCER (2007)
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
Ian Smith et al.
LANCET (2007)
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
A. A. Khorana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Radiation-induced cardiovascular diseases: Is the epidemiologic evidence compatible with the radiobiologic data?
Susanne Schultz-Hector et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition
Daniela Cardinale et al.
CIRCULATION (2006)
Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer
Russell D. Hull et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Prognosis value of atrial natriuretic peptide and brain natriuretic peptide for heart failure in patients undergoing allogeneic bone marrow transplantation
Hiroyuki Takatsuka et al.
HEMATOLOGY (2006)
Secondary prevention of venous thromboembolic events in patients with active cancer: Enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period
Steven R. Deitcher et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2006)
Long-term cardiac tolerability of trastuzumab in metastatic breast cancer: The M.D. Anderson Cancer Center experience
Valentina Guarneri et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Dietary patterns and survival after breast cancer diagnosis
CH Kroenke et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity
L Wojnowski et al.
CIRCULATION (2005)
Trends in the incidence of venous thromboembolism during pregnancy or postpartum: A 30-year population-based study
JA Heit et al.
ANNALS OF INTERNAL MEDICINE (2005)
Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31
E Tan-Chiu et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Reversibility of trastuzumab-related cardiotoxicity: New insights based on clinical course and response to medical treatment
MS Ewer et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
MJ Piccart-Gebhart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
EH Romond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
ML Sorror et al.
BLOOD (2005)
Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300 000 women in US SEER cancer registries
SC Darby et al.
LANCET ONCOLOGY (2005)
Weight, weight gain, and survival after breast cancer diagnosis
CH Kroenke et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Differential diagnosis of cardiac masses using contrast echocardiographic perfusion imaging
JN Kirkpatrick et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Carcinoid heart disease: Presentation, diagnosis, and management
DJ Fox et al.
HEART (2004)
Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: A staging system for primary systemic amyloidosis
A Dispenzieri et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Mitral and tricuspid valve repair in patients with previous mediastinal radiation therapy
JA Crestanello et al.
ANNALS OF THORACIC SURGERY (2004)
The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia
SE Lipshultz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease
J Zuetenhorst et al.
BRITISH JOURNAL OF CANCER (2004)
Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy
MC Hull et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer
AYY Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure -: Results of the Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial
ES Chung et al.
CIRCULATION (2003)
Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity
G Cianci et al.
BRITISH JOURNAL OF CANCER (2003)
Radiation-associated cardiovascular disease
MJ Adams et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2003)
Autonomic nervous system dysfunction in advanced cancer
D Walsh et al.
SUPPORTIVE CARE IN CANCER (2002)
Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer - A randomized controlled study
G Meyer et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Capecitabine can induce acute coronary syndrome similar to 5-fluorouracil
N Frickhofen et al.
ANNALS OF ONCOLOGY (2002)
Frequency and risk factors of anthracycline-induced clinical heart failure in children:: a systematic review
LCM Kremer et al.
ANNALS OF ONCOLOGY (2002)
Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.
D Bergqvist et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial
HJ Dargie et al.
LANCET (2001)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Assessment of cardiotoxicity during haemopoietic stem cell transplantation with plasma brain natriuretic peptide
JA Snowden et al.
BONE MARROW TRANSPLANTATION (2000)